Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adult Brain Glioblastoma × Ferrosoferric Oxide × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 5 Glioblastoma 4 Childhood Brain Neoplasm 2 Neurodegenerative Diseases 1 Ischemic Stroke 1 Hypoxia 1 Hemorrhagic Stroke 1 Glioma 1 Cranial Nerve Diseases 1 Central Nervous System Vascular Malformations 1 Central Nervous System Neoplasms 1 Central Nervous System Infections 1 Brain Injuries 1 Adult Brain Glioblastoma 1

Interventions

Gadolinium 1 Ferrosoferric Oxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00660543 2017-05-16

MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

OHSU Knight Cancer Institute

Phase NA Completed

14 enrolled 6 charts

Adult Brain Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡